News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

STADA Arzneimittel AG (STAGn.DE) Says Sells U.S. Unit For Around $40 Million


7/13/2006 10:35:48 AM

FRANKFURT, July 13 (Reuters) - German generic drugmaker Stada Arzneimittel (STAGn.DE: Quote, Profile, Research) has agreed to sell its unprofitable U.S. unit to New Jersey-based DAVA Pharmaceuticals for around $40 million, it said in a statement on Thursday.

Read at press release
Read at Reuters
Read at Bloomberg

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES